Xiongjun Wang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
-
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 5
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 3
-
- Cancer, Hypoxia, and Metabolism 13
- Co-authors
- Wencheng Zhu (12 shared papers)Weiwei Yang (8 shared papers)Ji Liang (6 shared papers)Hong Gao (7 shared papers)Yajuan Zhang (6 shared papers)Hua Yu (15 shared papers)Ruilong Liu (4 shared papers)Huiying Chu (5 shared papers)
- Journals
- Nature Communications (4 papers)Cell Research (2 papers)Molecular Therapy (2 papers)Cell Discovery (2 papers)Molecular Cell (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiongjun Wang
40 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 609
- Molecular Biology 1.0k
- Immunology 245
- Oncology 232
- Genetics 69
Countries citing papers authored by Xiongjun Wang
This map shows the geographic impact of Xiongjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongjun Wang more than expected).
Fields of papers citing papers by Xiongjun Wang
This network shows the impact of papers produced by Xiongjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongjun Wang. The network helps show where Xiongjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiongjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 262 | |
| 2 | 2018 | 234 | |
| 3 | 2019 | 154 | |
| 4 | 2020 | 153 | |
| 5 | 2019 | 120 | |
| 6 | 2019 | 112 | |
| 7 | 2019 | 85 | |
| 8 | 2021 | 74 | |
| 9 | 2019 | 59 | |
| 10 | 2018 | 54 | |
| 11 | 2013 | 39 | |
| 12 | 2021 | 38 | |
| 13 | 2019 | 38 | |
| 14 | 2020 | 36 | |
| 15 | 2020 | 27 | |
| 16 | 2023 | 26 | |
| 17 | 2018 | 25 | |
| 18 | 2019 | 25 | |
| 19 | 2024 | 25 | |
| 20 | 2015 | 24 |
About Xiongjun Wang
Xiongjun Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Epidemiology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Antifungal resistance and susceptibility (4 papers), Immune cells in cancer (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Cancer Research (609 citations), Molecular Biology (1.0k citations), Immunology (245 citations), Oncology (232 citations) and Genetics (69 citations). Xiongjun Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wencheng Zhu, Weiwei Yang, Ji Liang, Hong Gao, Yajuan Zhang, Hua Yu, Ruilong Liu, Huiying Chu, Ping Wei and Bangbao Tao. Their work appears in journals such as Nature Communications, Cell Research, Molecular Therapy, Cell Discovery and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.